To assess the feasibility of performing national, randomized trials of dietary interventions for localized prostate cancer.The Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]) is a phase III clinical trial testing the efficacy of a high-vegetable diet to prevent progression in patients with prostate cancer on active surveillance (AS). ...
To assess the feasibility of performing national, randomized trials of dietary interventions for localized prostate cancer.The Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]) is a phase III clinical trial testing the efficacy of a high-vegetable diet to prevent progression in patients with prostate cancer on active surveillance (AS). ...
Objectives : To assess the effects of a prostate cancer (PCa) clinical pathway on the implementation of evidence-based strategies for the management of androgen deprivation therapy (ADT)-induced side effects. Patients and Methods : A clinical pathway was introduced at hospital level in 2015. The pathway consists of evidence-based strategies for the...
Objectives : To assess the effects of a prostate cancer (PCa) clinical pathway on the implementation of evidence-based strategies for the management of androgen deprivation therapy (ADT)-induced side effects. Patients and Methods : A clinical pathway was introduced at hospital level in 2015. The pathway consists of evidence-based strategies for the...
Objectives : To assess the effects of a prostate cancer (PCa) clinical pathway on the implementation of evidence-based strategies for the management of androgen deprivation therapy (ADT)-induced side effects. Patients and Methods : A clinical pathway was introduced at hospital level in 2015. The pathway consists of evidence-based strategies for the...
Objectives : To assess the effects of a prostate cancer (PCa) clinical pathway on the implementation of evidence-based strategies for the management of androgen deprivation therapy (ADT)-induced side effects. Patients and Methods : A clinical pathway was introduced at hospital level in 2015. The pathway consists of evidence-based strategies for the...
Objectives : To assess the effects of a prostate cancer (PCa) clinical pathway on the implementation of evidence-based strategies for the management of androgen deprivation therapy (ADT)-induced side effects. Patients and Methods : A clinical pathway was introduced at hospital level in 2015. The pathway consists of evidence-based strategies for the...
Published in BJU international
Based on the present prospective single-centre experience, PHI density could be used to avoid 38% of unnecessary biopsies, while failing to detect only 2% of clinically significant cancers.
Published in BJU international
BDT is rare amongst patients with prostate cancer treated with ADT in this integrated delivery system. However, BDT was associated with substantially increased treatment of osteoporosis indicating an underappreciated burden of osteoporosis amongst prostate cancer survivors initiating ADT. Optimising BDT use and osteoporosis management in this at-ri...
Published in BJU international
Men with PCa previously treated long-term with ADT respond more favourably to exercise in terms of lower body muscle performance and body composition (lean and fat mass, and ASM) than those with short-term ADT exposure. As a result, men who were formerly on long-term androgen suppression regimens should be especially prescribed exercise medicine in...
